Search clinical trials for: A.2 Lucinactant

Total 25708 results

Windtree Therapeutics

Terminated

KL₄Surfactant Treatment in Patients With ARDS

Acute Respiratory Distress Syndrome

United States
Windtree Therapeutics

Terminated

SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.

Premature Birth | Respiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia

United States
Windtree Therapeutics

Completed

The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

Respiratory Distress Syndrome

United States, Canada, Colombia, Hungary, Chile, Ireland, Netherlands, Poland
University of North Carolina, Chapel Hill
Windtree Therapeutics; Cystic Fibrosis Foundation

Completed

Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease

Cystic Fibrosis

United States
Windtree Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

Respiratory Distress Syndrome

United States
Windtree Therapeutics

Terminated

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Respiratory Distress Syndrome

Canada, United States, Chile, Poland
Windtree Therapeutics

Terminated

A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age

Respiratory Distress Syndrome, Newborn

Poland
Coopervision, Inc.

Completed

A Clinical Comparison of Three Soft Daily Disposable Contact Lenses

Myopia

United Kingdom
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Investigational Contact Lenses

Visual Acuity

Hong Kong
Windtree Therapeutics

Completed

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

COVID-19 | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

United States, Argentina
Windtree Therapeutics

Terminated

Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants

Respiratory Distress Syndrome

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluation of Two Marketed Multifocal Contact Lenses

Visual Performance

United States
University Hospital, Strasbourg, France

Completed

Effect of Immersion, Performed Under the Conditions of Obstetrical Dilatation Bath, on Diuresis and Hemodynamic Variables in Young Women (IMMERSION)

Healthy

France
Windtree Therapeutics

Completed

Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old (KL4-AHRF-01)

Acute Hypoxemic Respiratory Failure

United States, Chile
Roswell Park Cancer Institute

Withdrawn

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

Esophageal Neoplasm
Johnson & Johnson Vision Care, Inc.

Completed

Influence of Lens Design on Particulate Exchange in the Post-lens Tear Film

Visual Acuity

United Kingdom
Catherine Bollard

Active, not recruiting

Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma (ALCI2)

Hodgkin Disease | Non Hodgkin Lymphoma | Leiomyosarcoma | Lymphoepithelioma | Severe Chronic Active EBV Infection Syndrome (SCAEBV)

United States
Windtree Therapeutics

Terminated

Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome

Meconium Aspiration

United States
Marmara University

Not yet recruiting

Oral Motor Intervention to Preterms by Their Mothers

Premature

Turkey
Hangzhou GluBio Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloid Malignancy

China
GluBio Therapeutics Inc.

Recruiting

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses

Visual Acuity

United States, Hong Kong
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
Technische Universität Dresden
AOK Bayern; Techniker Krankenkasse; InGef - Institut für angewandte Gesundheitsforschung... and other collaborators

Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data (POINTED)

Virus Diseases | Epidemiology

Germany
MDM S.p.A.
Opera CRO, a TIGERMED Group Company

Completed

Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS

Metabolic Syndrome

Romania
Technische Universität Dresden
Techniker Krankenkasse; InGef - Institut für angewandte Gesundheitsforschung... and other collaborators

Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD) (POINTED-AD)

Virus Diseases

Germany
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Dyslipidemias

Korea, Republic of
LumiraDx UK Limited

Suspended

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites (PURSUE)

COVID-19 | SARS-CoV-2 | Influenza A | Influenza B

United States
University of Alberta

Completed

Pilot Test of a Chinese Menu Plan for Type 2 Diabetes

Type 2 Diabetes
Science and Technology Park, Center of Innovation...
University in Zielona Góra

Completed

Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients

Lung Cancer

Poland
Coopervision, Inc.

Completed

A Clinical Performance of Two Soft Toric Contact Lenses

Astigmatism

United Kingdom
Coopervision, Inc.

Completed

A Clinical Comparison of Two Daily Disposable Soft Contact Lenses

Myopia

United Kingdom
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
Natural Immune Systems Inc

Recruiting

Immunological Effect of Increasing Doses of Natural Peptide

Pharmacokinetics

United States
Coopervision, Inc.

Completed

Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses

Myopia

United States
University of Minnesota
University of California, San Francisco; Posit Science Corporation

Completed

D2D Normative Data for Remote Assessments

Cognition

United States
Chinese Society of Hematology
Harbin Institute of Hematology & Oncology

Unknown

Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study (MD-CHINA)

Myelodysplastic Syndrome (MDS)
Charles Drew University of Medicine and Science

Withdrawn

Preventing and Managing Cognitive Impairment (CognitnECHO)

Cognitive Impairment | Knowledge Translation
National Institute of Allergy and Infectious Diseases...

Completed

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

Influenza

United States
Johnson & Johnson Vision Care, Inc.

Completed

A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One Week

Visual Disorder

India
University of Houston

Completed

Evaluation of Visual Performance With Contact Lenses

Myopia

United States
Coopervision, Inc.

Completed

Study of Soft Contact Lens Use With 7 Day Extended Wear

Ametropia

United States
OHSU Knight Cancer Institute
Lance Armstrong Foundation

Completed

Exercise for Physical Health in Men With Prostate Cancer

Osteoporosis | Prostatic Neoplasm

United States
Coopervision, Inc.

Completed

Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear

Myopia

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (ALCI)

Hodgkin Disease | Non Hodgkin Lymphoma | Leiomyosarcoma | Lymphoepithelioma

United States
Mayo Clinic
Stryker Nordic

Completed

Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty

Glenohumeral Joint Degeneration

United States
Johnson & Johnson Vision Care, Inc.

Completed

Open Eye Corneal Swelling With Daily Disposable Contact Lenses and no Lens Wear

Corneal Swelling

Canada
National Institute of Allergy and Infectious Diseases...

Completed

2013/2017 H7N9 Prime-Boost Interval

Influenza Immunisation | Avian Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

H7N9 Mix and Match With MF59 in Healthy Adults

Influenza

United States

Search clinical trials for: A.2 Lucinactant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations